SS

Sonali Srivastava

Active Director Director DIN 10751932
DIN 10751932 First appointment Aug 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Aug 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Sonali Srivastava

Data last updated:

Sonali Srivastava is a Director at Kalawa Multinational Private Limited (since 2024) and Director at Kalawa Multinational Pharmaceutical Private Limited (since 2024).

DIN 10751932
Primary Designation Director
First Appointment 23 Aug 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kalawa Multinational Private Limited U95299UP2024PTC210090
Director01 Oct 20242024Active
Director23 Aug 20242024Active

Board colleagues of Sonali Srivastava

Directorship timeline

Open interactive timeline →
Kalawa Multinational Private Limited
Kalawa Multinational Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Sonali Srivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sonali Srivastava

Sonali Srivastava currently holds 2 directorships: Kalawa Multinational Private Limited (Director, since 01 Oct 2024); Kalawa Multinational Pharmaceutical Private Limited (Director, since 23 Aug 2024).

Sonali Srivastava was first appointed on 23 Aug 2024 as Director at Kalawa Multinational Pharmaceutical Private Limited.

The current boards of Sonali Srivastava's companies include Bindiya Verma (Kalawa Multinational Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available